Pharmaceuticals

Rotavirus Vaccine Market Forecast 2026–2030 Presenting Long-Term Industry Insights

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Rotavirus Vaccine Market Compare Between 2026 And 2030?

The rotavirus vaccine market has experienced rapid growth in recent years. It is projected to expand from $10.14 billion in 2025 to $11.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. Historically, this growth can be attributed to factors such as a rising incidence of pediatric gastroenteritis, the expansion of national immunization programs, the proliferation of public health vaccination campaigns, the availability of live attenuated vaccines, and increased awareness regarding rotavirus prevention.

The rotavirus vaccine market is projected for substantial expansion in the coming years. This market is forecast to reach $16.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Key drivers for this growth during the projection period include a surge in demand for widespread pediatric vaccination, the development of more combination vaccines, greater investments in vaccine production capabilities, an elevated emphasis on global immunization, and stronger partnerships with public health bodies. Significant trends anticipated in the same timeframe encompass the broadening of pediatric immunization initiatives, a higher uptake of oral vaccine formats, intensified efforts towards optimizing the vaccine cold chain, the expansion of public health vaccination efforts, and improved monitoring of rotavirus infections.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

Which Primary Drivers Are Impacting The Rotavirus Vaccine Market Growth?

An anticipated expansion in the rotavirus vaccine market is linked to an increase in birth rates. Birth rates represent the count of live births per thousand individuals within a given timeframe, typically measured annually. These rates are affected by enhanced economic stability and development, alongside supportive government initiatives such as parental leave, child support, and childcare assistance. Rotavirus vaccines play a crucial role in lowering the occurrence of severe rotavirus gastroenteritis among infants, which in turn betters children’s health and decreases medical expenditures tied to these infections. For example, a January 2023 report from the US-based national public health body, the Centers for Disease Control and Prevention, indicated a 1% rise in recorded births in the United States, reaching a total of 3,664,292, compared to the preceding year. Consequently, an uptick in birth rates is set to fuel the growth of the rotavirus vaccine market.

How Is The Rotavirus Vaccine Market Organized By Segment Classification?

The rotavirus vaccine market covered in this report is segmented –

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

Which Trends Are Guiding The Direction Of The Rotavirus Vaccine Market?

Leading companies within the rotavirus vaccine market are increasingly adopting oral-dosing applicators to enhance the efficiency of vaccine delivery and improve patient compliance. These oral-dosing applicators are medical devices specifically designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For example, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, and Emory University, a U.S.-based private university, initiated a first-in-human clinical trial for the inactivated rotavirus vaccine CC24, delivered using a dissolvable microarray patch. This patch is characterized by its thermostability (reducing dependence on the cold chain), its ability for self-administration, and the absence of sharps waste. This innovation holds promise for increasing vaccine access in low-resource settings; however, regulatory pathways are yet to be tested, and risks associated with scaling up production might delay its widespread adoption in the rotavirus vaccine market.

Who Are The Industry Participants Involved In The Rotavirus Vaccine Market?

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Get The Full Rotavirus Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Which Region Leads The Rotavirus Vaccine Market In Terms Of Market Share?

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Rotavirus Vaccine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Browse Through More Reports Similar to the Global Rotavirus Vaccine Market 2026, By The Business Research Company

Meningococcal Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795